BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29847859)

  • 1. The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner.
    Rea K; McGowan F; Corcoran L; Roche M; Finn DP
    Br J Pharmacol; 2019 May; 176(10):1492-1505. PubMed ID: 29847859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates.
    Butler RK; Rea K; Lang Y; Gavin AM; Finn DP
    Pain; 2008 Dec; 140(3):491-500. PubMed ID: 19004548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.
    Olango WM; Roche M; Ford GK; Harhen B; Finn DP
    Br J Pharmacol; 2012 Apr; 165(8):2549-60. PubMed ID: 21564082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats.
    Ford GK; Kieran S; Dolan K; Harhen B; Finn DP
    Pain; 2011 Nov; 152(11):2495-2504. PubMed ID: 21864979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase.
    Butler RK; Ford GK; Hogan M; Roche M; Doyle KM; Kelly JP; Kendall DA; Chapman V; Finn DP
    J Psychopharmacol; 2012 Jan; 26(1):83-91. PubMed ID: 21926424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of fear-conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB
    Corcoran L; Mattimoe D; Roche M; Finn DP
    Br J Pharmacol; 2020 May; 177(10):2240-2255. PubMed ID: 31967664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats.
    Rea K; Olango WM; Harhen B; Kerr DM; Galligan R; Fitzgerald S; Moore M; Roche M; Finn DP
    Pain; 2013 Apr; 154(4):576-585. PubMed ID: 23414578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel molecular correlates of endocannabinoid-mediated fear-conditioned analgesia in rats.
    Olango WM; Géranton SM; Roche M; Hunt SP; Finn DP
    Eur J Pain; 2014 Feb; 18(2):182-91. PubMed ID: 23873727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
    Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP
    Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
    Vimalanathan A; Gidyk DC; Diwan M; Gouveia FV; Lipsman N; Giacobbe P; Nobrega JN; Hamani C
    Neuropharmacology; 2020 Apr; 166():107965. PubMed ID: 31962287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats.
    Roche M; O'Connor E; Diskin C; Finn DP
    Eur J Neurosci; 2007 Nov; 26(9):2643-53. PubMed ID: 17970731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear.
    Roche M; Johnston P; Mhuircheartaigh ON; Olango WM; Mackie K; Finn DP
    Eur J Pain; 2010 May; 14(5):487-95. PubMed ID: 19786358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
    Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medial prefrontal cortex serotonergic and GABAergic mechanisms modulate the expression of contextual fear: intratelencephalic pathways and differential involvement of cortical subregions.
    Almada RC; Coimbra NC; Brandão ML
    Neuroscience; 2015 Jan; 284():988-997. PubMed ID: 25451298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Intra-BLA Administration of PPAR Antagonists on Formalin-Evoked Nociceptive Behaviour, Fear-Conditioned Analgesia, and Conditioned Fear in the Presence or Absence of Nociceptive Tone in Rats.
    Gaspar JC; Okine BN; Dinneen D; Roche M; Finn DP
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A; Giuffrida A
    Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
    Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors.
    Finn DP; Beckett SR; Richardson D; Kendall DA; Marsden CA; Chapman V
    Eur J Neurosci; 2004 Aug; 20(3):848-52. PubMed ID: 15255996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis.
    Murillo-Rodríguez E; Machado S; Rocha NB; Budde H; Yuan TF; Arias-Carrión O
    Neuroscience; 2016 Dec; 339():433-449. PubMed ID: 27746343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.